ENHANCEMENT OF DISSOLUTION RATE AND FORMULATION DEVELOPMENT OF EFAVIRENZ TABLETS EMPLOYING STARCH PHOSPHATE A NEW MODIFIED STARCH
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2011, Vol 3, Issue 2
Abstract
The objective of the study is to prepare, characterize and evaluate starch phosphate, a new modified starch as a carrier in solid dispersions for enhancing the dissolution rate of Efavirenz. The feasibility of formulating solid dispersions of Efavirenz in starch phosphate into compressed tablets with enhanced dissolution rate was also investigated. Starch phosphate was prepared by reacting starch with di-sodium hydrogen orthophosphate anhydrous at elevated temperatures. It was insoluble in water and has good swelling (400%) property without pasting or gelling when heated in water. Solid dispersions of Efavirenz in starch phosphate were prepared by solvent evaporation method employing various weight ratios of drug: starch phosphate such as 2:1(SD-1), 1:1(SD-2), 1:2(SD-3), 1:3(SD-4) and 1:9(SD-5) and were evaluated for dissolution rate and efficiency. All the solid dispersions prepared gave rapid and higher dissolution of Efavirenz when compared to pure drug. Dissolution followed first order kinetics. A 13.98 and 31.37 fold increase in the dissolution rate (K1) of Efavirenz was observed with solid dispersions SD-4 and SD-5 respectively. The DE30 was also increased from 10.66% in the case of Efavirenz pure drug to 51.13% and 71.51% in the case of these solid dispersions. Efavirenz (50 mg) tablets were prepared employing Efavirenz alone and its solid dispersions SD-3 and SD-4 by wet granulation method and were evaluated. Efavirenz tablets formulated employing its solid dispersions in starch phosphate gave rapid and higher dissolution rate and DE30 when compared to plain and commercial tablets. A 16.71 and 31.04 fold increase in the dissolution rate (K1) was observed with tablet formulations containing solid dispersions SD-3 and SD-4 respectively when compared to plain tablets.
Authors and Affiliations
K. P. R. Chowdary, Veeraiah Enturi
Keywords
Related Articles
- EP ID EP624962
- DOI -
- Views 49
- Downloads 0
DEVELOPMENT AND VALIDATION OF SIMPLE UV-SPECTROPHOTOMETRIC METHOD OF QUANTIZATION OF ONDANSETRON HYDROCHLORIDE IN SOLID DOSAGE FORMULATIONS USING HYDROTROPIC SOLUBILIZATION TECHNIQUE
Commonly used organic solvents for spectrophotometric analysis of water insoluble drugs are methanol, ethanol, chloroform, benzene, toluene etc. The main drawbacks of organic solvents include high cost, toxicity, and pol...
EXTRACTIVE SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF GABAPENTIN IN PHARMACEUTICAL DOSAGE FORMS
Two simple, rapid, sensitive, accurate, precise and economic spectrophotometric methods have been developed for the estimation of Gabapentin (GBP) in pharmaceutical formulations. During the course of study, it was observ...
ANTI-ARTHRITIC ACTIVITY OF ETHANOLIC EXTRACT OF ROOT OF MOMORDICA CHARANTIA AGAINST FCA INDUCED ARTHRITIS
The present investigation is aimed to evaluate anti-arthritic activity of the ethanol extract of root of Momordica charantia (EEMR) by using Freund’s complete adjuvant (FCA) induced arthritis model which is a extensively...
SIMPLE AND PRECISE UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT FOR ESTIMATION OF ALBENDAZOLE FOR DISSOLUTION STUDY
Albendazole is a class II drug in biopharmaceutical classification system, so its dissolution study is very difficult because of its low solubility and difficulty during estimation of drug in bulk. The present study deal...
CYTOTOXIC EFFECT AND PERMEABILITY ACTIVITIES OF CURCUMIN ANALOGUE; 2, 6-BIS (2, 5-DIMETHOXYBENZY-LIDENE) CYCLOHEXANONE (BDMC33) IN CACO-2 CELL MODEL
Previously, curcumin analogue, 2, 6-bis (2, 5-dimethoxybenzylidene) cyclohexanone (BDMC33) with high anti-inflammatory activity was chemically synthesized in our laboratory to enhance the biological activity of curcumin....